Access to experimental drugs for terminally ill patients

JAMA. 2008 Dec 17;300(23):2793-5. doi: 10.1001/jama.2008.828.
No abstract available

MeSH terms

  • Drug Industry
  • Drugs, Investigational*
  • Humans
  • Legislation, Drug*
  • Policy Making
  • Terminally Ill*
  • United States
  • United States Food and Drug Administration

Substances

  • Drugs, Investigational